disulfiram has been researched along with thyroxine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jahodová, J; Pribyl, T; Schreiber, V | 1 |
Gavaler, JS; Paul, GM; Smith, WI; Van Thiel, DH | 1 |
Borud, O; Gjessing, LR; Nishimura, T | 1 |
Gjessing, LR | 1 |
1 review(s) available for disulfiram and thyroxine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for disulfiram and thyroxine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
Topics: Animals; Ascorbic Acid; Ceruloplasmin; Disulfiram; Dopamine beta-Hydroxylase; Drug Interactions; Estradiol; Hypothalamus; Male; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Protein Binding; Rats; Thyroxine | 1979 |
Disulfiram-induced disturbances in hypothalamic-pituitary function.
Topics: Adult; Disulfiram; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Male; Prolactin; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1979 |
Studies on urinary phenolic compounds in man. I. Excretion of p-hydroxy-mandelic acid by man.
Topics: Amino Acid Metabolism, Inborn Errors; Chromatography; Disulfiram; Humans; In Vitro Techniques; Mandelic Acids; Methyldopa; Neuroblastoma; Octopamine; Phenelzine; Phenylketonurias; Thyroxine; Triiodothyronine; Tyrosine; Urine | 1965 |
Effect of thyroxine, pyridoxine, orphenadrine-HCl, resperine and disulfiram in periodic catatonia.
Topics: Basal Metabolism; Body Temperature; Body Weight; Catatonia; Catecholamines; Disulfiram; Humans; Injections, Intramuscular; Mandelic Acids; Normetanephrine; Orphenadrine; Periodicity; Pulse; Pyridoxine; Reserpine; Sleep; Thyroxine | 1967 |